Skip to content

Clinical Outcome of Two-piece Zirconia Implants in Immediate Implant Placement

Clinical Outcome of Two-piece Zirconia Implants in Immediate Implant Placement - a Prospective Randomized Controlled Clinical Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05369299
Enrollment
33
Registered
2022-05-11
Start date
2022-05-13
Completion date
2025-12-12
Last updated
2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immediate Implantation of Two-piece Zirconia Dental Implants

Keywords

zirconium oxide, Dental Implants, Prospective Studies, Osseointegration, Resonance Frequency Analysis, Patient Reported Outcome Measures, Esthetics

Brief summary

The purpose of the study is to test whether a two-piece zirconia implant is as reliable in the indication of immediate implant placement as a standard titanium implant.

Interventions

DEVICEImplant Straumann® Pure Ceramic Two Piece Implant

Dental implants are placed directly after tooth extraction in the extraction socket.

DEVICEtwo-piece titanium implant Neoss® ProActive Tapered Implant

Dental implants are placed directly after tooth extraction in the extraction socket.

Sponsors

Medical University of Graz
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Masking procedures are only applicable for the outcomes assessor. Due to the different colors of the compared implants, blinding procedures are not applicable for the investigator or the participants.

Intervention model description

prospective controlled randomized trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Patients giving informed consent to participate in the clinical trial and fulfil the following criteria will be included in the investigation: 1. good oral hygiene standard; 2. good general health; 3. 18 years or older; 4. non-smokers; 5. presence of single-tooth or multiple gaps in the mandible or the maxilla; 6. intact facial bone wall; 7. sufficient bone volume to support an implant of at least 10 mm length. 8. Teeth with removable periapical lesions are included.

Exclusion criteria

Primary

Design outcomes

Primary

MeasureTime frameDescription
Change of PTVinitial, 6 and 12 months after surgical procedurePeriotest value, Damping capacity assessment. For Periotest values, a customizable healing abutment will be inserted to assess damping capacity.
Change of ISQinitial, 6 and 12 months after surgical procedureImplant stability quotient. A transducer (smart-peg sensor) will be installed on the top of the implant to measure ISQ with resonance frequency analysis. ISQ will be measured from 4 different sites (facial, lingual, mesial, distal) and calculated as mean of measurements.

Secondary

MeasureTime frameDescription
Change of marginal bone loss6 and 12 months after surgical procedureA single radiography in paralleling technique will be performed to measure marginal bone loss in millimeters (mm). Individualized x-ray holders will be used to ensure standardization and comparability in radiographic procedure.
Change of PES6 and 12 months after surgical procedureIn the anterior region (4-4) the pink esthetic score (PES) (Fürhauser et al. 2005) will be used to evaluate the esthetic outcome of the soft tissue around the implant-supported single crowns by awarding seven points for the mesial and distal papilla, soft- tissue level, contour, colour, texture and alveolar process deficiency.
Change of width of keratinized mucosainitial, 12 months after surgical procedureThe width of keratinized mucosa will be measured in millimetres at the narrowest distance between the mucosal margin and the mucogingival junction at the buccal aspect of the implant using Lugol ́s iodine solution.
Change of BOPinitial, 6 and 12 months after surgical procedureBleeding on probing will be recorded as positive (BOP+) when bleeding of the peri-implant mucosa is detected at implant (tooth) site-level after probing depth assessment within periodontal status.
Gingival biotypeinitialThe tissue phenotype/gingival biotype will be classified at first visit with a conventional periodontal probe. Phenotype will be classified as thin, if the outline of the underlying probe can be seen shining through the buccal mucosa and as thick phenotype, if not.
Mean insertion timeat time of surgeryTime of implant insertion in seconds (sec).
Change of PROMinitial, 12 months after surgical procedurePatient related outcome measures. Patients ́ oral-health related quality of life will be assessed before and 12 months after implant therapy by using a 14-point standardized questionnaire (OHIP-14).
Complications - biologicalat time of surgical procedure, 2 weeks, 6 months and 12 months after surgical procedureAppearance of biological complications will be recorded in writing. Biological implant complications present the inflammatory reactions on peri-implant tissues, including peri-implant mucositis, peri-implantitis and implant loss.
Complications - technicalat time of surgical procedureAppearance of technical complications will be recorded in writing. Technical complications as abutment screw fractures, fractures or chipping of prosthetics may appear due to biomechanical overloading and will be recorded.
Complications - estheticat time of surgical procedureAppearance of esthetic complications will be recorded in writing. Gingival recession or lack of interdental papillae account for implant esthetic complications and will be recorded.

Countries

Austria

Contacts

PRINCIPAL_INVESTIGATORRaoul Polansky, DMD

Department of Dentistry and Oral Health, Medical University of Graz

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026